Evidence map›Paper›PMID 42827786›Full record

ArticleFrontiers in epidemiology2026

Low prevalence of

Martha N Kivecu, Victor Mobegi, Cavin Mgawe, Brenda M Kania, Gladys C Chemwor, Raphael O Okoth, Edwin W Mwakio, George Obiero, Jennifer M Mutisya, Jackline A Juma and 8 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in epidemiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Martha N KivecuMalaria Drug Resistance program, Kenya Medical Research Institute (KEMRI)/Walter Reed Army Institute of Research - Africa (WRAIR-A), Kisumu, Kenya.
Victor MobegiCentre for Biotechnology and Bioinformatics (CEBIB), University of Nairobi, Nairobi, Kenya.
Cavin MgaweBiosciences Department, KEMRI Wellcome Trust Research Programme, Kilifi, Kenya.
Brenda M KaniaMalaria Drug Resistance program, Kenya Medical Research Institute (KEMRI)/Walter Reed Army Institute of Research - Africa (WRAIR-A), Kisumu, Kenya.
Gladys C ChemworMalaria Drug Resistance program, Kenya Medical Research Institute (KEMRI)/Walter Reed Army Institute of Research - Africa (WRAIR-A), Kisumu, Kenya.
Raphael O OkothMalaria Drug Resistance program, Kenya Medical Research Institute (KEMRI)/Walter Reed Army Institute of Research - Africa (WRAIR-A), Kisumu, Kenya.
Edwin W MwakioMalaria Drug Resistance program, Kenya Medical Research Institute (KEMRI)/Walter Reed Army Institute of Research - Africa (WRAIR-A), Kisumu, Kenya.
George ObieroCentre for Biotechnology and Bioinformatics (CEBIB), University of Nairobi, Nairobi, Kenya.
Jennifer M MutisyaMalaria Drug Resistance program, Kenya Medical Research Institute (KEMRI)/Walter Reed Army Institute of Research - Africa (WRAIR-A), Kisumu, Kenya.
Jackline A JumaMalaria Drug Resistance program, Kenya Medical Research Institute (KEMRI)/Walter Reed Army Institute of Research - Africa (WRAIR-A), Kisumu, Kenya.
Agnes C CheruiyotMalaria Drug Resistance program, Kenya Medical Research Institute (KEMRI)/Walter Reed Army Institute of Research - Africa (WRAIR-A), Kisumu, Kenya.
Benjamin H OpotMalaria Drug Resistance program, Kenya Medical Research Institute (KEMRI)/Walter Reed Army Institute of Research - Africa (WRAIR-A), Kisumu, Kenya.
Amanda L RothMalaria Drug Resistance program, Kenya Medical Research Institute (KEMRI)/Walter Reed Army Institute of Research - Africa (WRAIR-A), Kisumu, Kenya.
Bernhards R OgutuCenter for Clinical Research, Kenya Medical Research Institute (KEMRI), Nairobi, Kenya.
Dennis W JumaMalaria Drug Resistance program, Kenya Medical Research Institute (KEMRI)/Walter Reed Army Institute of Research - Africa (WRAIR-A), Kisumu, Kenya.
Lynette Isabella Ochola-OyierBiosciences Department, KEMRI Wellcome Trust Research Programme, Kilifi, Kenya.
Ben AndagaluMalaria Drug Resistance program, Kenya Medical Research Institute (KEMRI)/Walter Reed Army Institute of Research - Africa (WRAIR-A), Kisumu, Kenya.
Hoseah M AkalaMalaria Drug Resistance program, Kenya Medical Research Institute (KEMRI)/Walter Reed Army Institute of Research - Africa (WRAIR-A), Kisumu, Kenya.

Funding

Wellcome Trust
6 · The paper itself

Abstract

Rapid and accurate malaria diagnosis is essential for effective treatment and malaria control. In Kenya, most malaria testing relies on

Indexed as

histidine-rich protein 2malaria rapid diagnostic testspfhrp2/pfhrp3 gene deletionspfhrp2/pfhrp3 genotypingplasmodium falciparum

Identifiers

PMID42827786
PMCPMC13630768

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.